Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Standard Lithium Ltd (SLI) Price & Performance

Abeona Therapeutics IncTrade
Standard Lithium LtdTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Standard Lithium Ltd — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Standard Lithium Ltd is the larger of the two by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.

ABEOSLI
Market Cap
$421.19M$604.50M
Sector
HealthBasic Materials
52-Week High
$7.45$5.65
52-Week Low
$4.17$1.93
Enterprise Value
$276.10M$467.42M

Returns comparison

Trailing returns across standard periods

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Standard Lithium Ltd

Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.

Read more on SLI